Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets

Der Nervenarzt
M A BuscheH Förstl

Abstract

Alzheimer's disease (AD) is characterized by the pathological accumulation of amyloid-beta (Abeta) and tau peptides in the brain. Recent evidence suggests that the soluble peptide amyloid-eta (Aeta) may have an additional role in the pathogenesis of AD. The detailed investigation of the cellular and neurophysiological mechanisms underlying AD has revealed surprising results that may become highly relevant for the early diagnosis and treatment of the disease. By analyzing the function of single neurons and large-scale networks in intact brains in vivo it has been shown that A-beta, tau and A-eta abnormally modulate brain activity and obviously unfold contrasting effects: while A-beta promotes neuronal hyperactivity as well as epileptiform activity, tau and A-eta reduce the activity of neurons. Promising new evidence from animal studies and humans with AD indicates that the treatment of hyperactivity may improve cognitive dysfunctions and even slow the underlying disease process.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Aug 17, 2000·The New England Journal of Medicine·S Y BookheimerG W Small
Oct 26, 2002·Science·Dennis J Selkoe
Apr 3, 2003·Neuron·Flavio KamenetzRoberto Malinow
Jun 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christoph StosiekArthur Konnerth
Jul 22, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iain A WilsonHeikki Tanila
Aug 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Randy L BucknerMark A Mintun
Dec 21, 2005·Neuron·John R CirritoDavid M Holtzman
May 12, 2006·Epilepsia·Joan C AmatniekYaakov Stern
Aug 1, 2006·Lancet·Kaj BlennowHenrik Zetterberg
Aug 26, 2006·Science·Jonathan R WhitlockMark F Bear
May 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Francesca CacucciJohn O'Keefe
Feb 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Robert M KoffieTara L Spires-Jones
Apr 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nicola FilippiniClare E Mackay
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
Oct 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yaisa Andrews-ZwillingYadong Huang
Jan 5, 2011·Annals of Neurology·Yakeel T QuirozChantal E Stern
Jan 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Erik D RobersonLennart Mucke
Feb 15, 2011·Neurobiology of Aging·R Heiner SchirmerEckhard Mandelkow
Mar 15, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Thomas M LancasterDavid E J Linden
May 3, 2011·Nature Neuroscience·Adam W BeroDavid M Holtzman
May 11, 2011·Neuron·Meaghan MorrisLennart Mucke
Apr 12, 2012·Nature Communications·Christine GrienbergerArthur Konnerth
May 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Marc Aurel BuscheArthur Konnerth
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Pascal E SanchezLennart Mucke
Aug 28, 2012·Nature Neuroscience·Nikita RudinskiyBradley T Hyman
Oct 10, 2012·BMJ : British Medical Journal·Sophie Billioti de GageAntoine Pariente
Jul 10, 2013·JAMA Neurology·Keith A VosselLennart Mucke

❮ Previous
Next ❯

Citations

Jun 5, 2018·Neural Regeneration Research·Zhi-You CaiZun-Yu Ke
Jun 22, 2021·Neurochemistry International·Saifudeen IsmaelTauheed Ishrat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.